Stay connected for the latest Syngulon news and updates on LinkedIn. We share developments on our bacteriocin-based technologies, including antibiotic-free selection, contamination control and therapeutic applications, as well as news on partnerships, patents, scientific developments and industry events.

Latest Press Release

SYNGULON ANNOUNCES LICENSING AGREEMENT WITH ELANCO ANIMAL HEALTH
Charleroi, Belgium, March 25, 2026 — SYNGULON SRL, a biotechnology company specializing in genetic technologies for industrial fermentation, and Elanco Animal Health Incorporated, a global leader in animal health, today announced Elanco has obtained a worldwide license to Syngulon’s proprietary bacteriocin based microbial selection technologies for use in the development and manufacture of animal health products.

Read the full press release (PDF)